Advanced Cell Technology, Inc…
Month: November 2010
Mimetogen Pharmaceuticals Announces Initiation Of Phase II Clinical Trial Of Novel NGF Mimetic In Patients With Dry Eye
Mimetogen Pharmaceuticals Inc., a clinical-stage biotechnology company focused on developing novel small molecule compounds that mimic the effects of neurotrophins, today announced that it has initiated the first human clinical trial evaluating MIM-D3,…
USFDA grants Sun Pharma tentative marketing approval for generic Cymbalta
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Cymbalta®, duloxetine hydrochloride delayed-release capsules.
New Compact Digital Retinal Camera From Canon Receives Clearance from FDA
Canon announced last week that its CR-2 Digital Non-Mydriatic Retinal Camera had received 510(k) clearance from the FDA.
New Laser System From OpticaMedica Uses Femto-Second Laser and Optical Coherence Tomography to Perform More Precise Cataract Surgery
OptiMedica Corp. last week announced the results of a clinical study of its Catalys Precision Laser System showing that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several critical steps of cataract surgery. Catalys is designed to perform four incisions: capsulotomy (a circular incision in […]
New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to ta…
Stargardt Disease To Be Treated With Embryonic Stem Cells in Trial Initiated by Advanced Cell Technology
Earlier this week, Advanced Cell Technology’s request to begin treating patients with Stargardt disease (also known as fundus flavimaculatus) with embryonic stem cells in a clinical trial was approved by the FDA. This will be the second trial using human…
New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to ta…
Surgeon Laments Limited Availability Of Cross-Linking In US
Although UV-riboflavin collagen cross-linking is currently undergoing clinical trials in the United States, one surgeon expressed dissatisfaction that the procedure still lacks U.S. Food and Drug Administration approval for treating corneal disorders s…
An Unresponsive Baby Boy
What condition do you suspect is present in this 10-month-old boy who was found unresponsive at home? Medscape Ophthalmology
Tallis PR: Ophthalmos Collects Platinum Award for Lens-Free Ophthalmoscope
LONDON–(BUSINESS WIRE)–New screening device wins at Nursing Times Product Awards Optyse™, the lens-free ophthalmoscope has been recognised with a Platinum Award in the Patient Observation category at the inaugural Nursing Times Product Awards. The …
HOYA Vision Care discusses technological developments and future of progressive lenses at Global PAL Summit
From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and s…
Management of Orbital Fractures
Technology Spotlight
HOYA Faculty Education & Experience Centre Officially Opens Its Doors
On Tuesday evening November 9th around 110 invitees witnessed the opening ceremony of HOYA’s new Faculty Education and Experience Centre in the heart of Budapest.
Acrylic IOLs May Unfold Faster After Warming Lenses, Viscoelastics, Saline
Surgeons performing acrylic IOL implantation can speed the unfolding of acrylic IOLs in the eye by using commercially available warming devices in the operating room to warm IOLs, viscoelastics and saline solution, a presenter said here.
Acrylic IOLs May Unfold Faster After Warming Lenses, Viscoelastics, Saline
Surgeons performing acrylic IOL implantation can speed the unfolding of acrylic IOLs in the eye by using commercially available warming devices in the operating room to warm IOLs, viscoelastics and saline solution, a presenter said here.
HOYA Discusses The Future Of Progressive Lenses On A Global Level
From 27 September until 1 October HOYA Vision Care invited a selection of its best lens experts and VIP customers from all over the world to join its Global PAL Summit in La Toja, Spain. Goal was to discuss in depth new technological developments and s…
Stem Cells in Ophthalmology Update 2: ACT Gets Go-ahead to Treat Stargardt’s
As I noted in my September report on the Use of Stem Cells in Ophthalmology, it was anticipated that either the program at The London Project to Cure Blindness or Advanced Cell Technology’s program to treat Stargardt’s disease would be…
VEGF Trap-Eye Treats Macular Degeneration
VEGF Trap-Eye is a new injectable medication that blocks VEGF for the treatment of wet macular degeneration. It may be as good as Lucentis, but not given as often.
Common Corneal Condition Associated With Increased Eye Pressure
Corneal arcus, a condition in which a ring of lipids builds up around the cornea, appears common among middle-age and older adults and may be associated with elevated eye pressure, according to a report in the November issue of Archives of Ophthalmolog…